OBJECTIVE: To estimate serum human chorionic gonadotropin (hCG) regression in uneventful complete hydatidiform moles before and after the introduction of routine first-trimester ultrasonography. METHODS: Gestational age, maternal age, preevacuation hCG concentrations, serum hCG regression, and hCG disappearance time among a recent group of 137 women with uneventful complete hydatidiform moles that were found between 1994 and 2006 were evaluated retrospectively and compared with a historical cohort of 106 patients with complete moles that were found between 1977 and 1989. RESULTS: Gestational age, preevacuation hCG concentration, and hCG disappearance time were significantly lower in the recent complete hydatidiform mole cohort compared with...
OBJECTIVE: To quantify the risk of developing post-molar gestational trophoblastic neoplasia (pGTN) ...
Objective. To compare the clinical presentation and incidence of postmolar gestational trophoblastic...
OBJECTIVE: Human chorionic gonadotrophin (hCG) follow-up data were analysed retrospectively in all p...
OBJECTIVE: To investigate whether the glycoform distribution patterns of human chorionic gonadotropi...
Contains fulltext : 50098.pdf (publisher's version ) (Closed access)OBJECTIVE: The...
OBJECTIVE: Human chorionic gonadotropin (hCG) is widely used in the management of hydatidiform mole ...
Objective: The aim of this study was to reach a publicly applicable marker, using the increasing or ...
Item does not contain fulltextAfter the evacuation of a hydatidiform mole, the spontaneous regressio...
Contains fulltext : 138210.pdf (Publisher’s version ) (Closed access)OBJECTIVE: Th...
OBJECTIVE: Human chorionic gonadotropin (hCG) is widely used in the management of hydatidiform mole ...
OBJECTIVE: To quantify the risk of developing post-molar gestational trophoblastic neoplasia (pGTN) ...
Contains fulltext : 70470.pdf (publisher's version ) (Closed access)The objective ...
SummaryBackgroundIndications for chemotherapy in gestational trophoblastic disease include raised hu...
Introduction: Partial molar trophoblast degeneration is a benign disease characterised by numerous c...
OBJECTIVES: To determine the risk for recurrent trophoblastic disease after spontaneous normalizatio...
OBJECTIVE: To quantify the risk of developing post-molar gestational trophoblastic neoplasia (pGTN) ...
Objective. To compare the clinical presentation and incidence of postmolar gestational trophoblastic...
OBJECTIVE: Human chorionic gonadotrophin (hCG) follow-up data were analysed retrospectively in all p...
OBJECTIVE: To investigate whether the glycoform distribution patterns of human chorionic gonadotropi...
Contains fulltext : 50098.pdf (publisher's version ) (Closed access)OBJECTIVE: The...
OBJECTIVE: Human chorionic gonadotropin (hCG) is widely used in the management of hydatidiform mole ...
Objective: The aim of this study was to reach a publicly applicable marker, using the increasing or ...
Item does not contain fulltextAfter the evacuation of a hydatidiform mole, the spontaneous regressio...
Contains fulltext : 138210.pdf (Publisher’s version ) (Closed access)OBJECTIVE: Th...
OBJECTIVE: Human chorionic gonadotropin (hCG) is widely used in the management of hydatidiform mole ...
OBJECTIVE: To quantify the risk of developing post-molar gestational trophoblastic neoplasia (pGTN) ...
Contains fulltext : 70470.pdf (publisher's version ) (Closed access)The objective ...
SummaryBackgroundIndications for chemotherapy in gestational trophoblastic disease include raised hu...
Introduction: Partial molar trophoblast degeneration is a benign disease characterised by numerous c...
OBJECTIVES: To determine the risk for recurrent trophoblastic disease after spontaneous normalizatio...
OBJECTIVE: To quantify the risk of developing post-molar gestational trophoblastic neoplasia (pGTN) ...
Objective. To compare the clinical presentation and incidence of postmolar gestational trophoblastic...
OBJECTIVE: Human chorionic gonadotrophin (hCG) follow-up data were analysed retrospectively in all p...